AAAAAA

   
Results: 1-25 | 26-50 | 51-61
Results: 1-25/61
USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS
Authors: ROMAGUERA JE DIAZPAVON JR CARIAS L HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA SARRIS AH YOUNES A PRETI A BACHIER C LLERENA E CABANILLAS F
Citation: Je. Romaguera et al., USE OF THE INTERNATIONAL PROGNOSTIC INDEX AND THE TUMOR SCORE TO DETECT POOR-RISK PATIENTS WITH PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA -A STUDY OF 37 PREVIOUSLY UNTREATED PATIENTS, Leukemia & lymphoma, 28(3-4), 1998, pp. 295-306
ALTERNATING TRIPLE THERAPY FOR THE TREATMENT OF INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA
Authors: CABANILLAS F PAVON JRD HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA ROMAGUERA JE DONG K MOON T
Citation: F. Cabanillas et al., ALTERNATING TRIPLE THERAPY FOR THE TREATMENT OF INTERMEDIATE GRADE AND IMMUNOBLASTIC LYMPHOMA, Annals of oncology, 9(5), 1998, pp. 511-518
SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS
Authors: LIAO ZX HA CS FULLER LM HAGEMEISTER FB CABANILLAS F TUCKER SL HESS MA COX JD
Citation: Zx. Liao et al., SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS, International journal of radiation oncology, biology, physics, 41(5), 1998, pp. 1047-1056
HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II
Authors: FULLER LM MIRZA NQ PALMER JL DAVIS BR HA CS RODRIGUEZ MA HAGEMEISTER FB CABANILLAS F MCLAUGHLIN P BUTLER JJ NORTH LB MARTIN RG
Citation: Lm. Fuller et al., HODGKINS-DISEASE - CORRELATION OF CLINICAL CHARACTERISTICS WITH PROBABILITIES FOR NEGATIVE LYMPHANGIOGRAM VS. NEGATIVE LAPAROTOMY FINDINGS IN PATIENTS WITH STAGE-I SUPRADIAPHRAGMATIC PRESENTATIONS VS. THOSE INPATIENTS WITH STAGE-II, International journal of radiation oncology, biology, physics, 40(2), 1998, pp. 377-386
PRIMARY PANCREATIC LYMPHOMA
Authors: BOUVET M STAERKEL GA SPITZ FR CURLEY SA CHARNSANGAVEJ C HAGEMEISTER FB JANJAN NA PISTERS PWT EVANS DB
Citation: M. Bouvet et al., PRIMARY PANCREATIC LYMPHOMA, Surgery, 123(4), 1998, pp. 382-390
STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997
Authors: VLACHAKI MT HA CS HAGEMEISTER FB FULLER LM RODRIGUEZ MA HESS MA TUCKER SL CABANILLAS F COX JD
Citation: Mt. Vlachaki et al., STAGE-I HODGKIN DISEASE - RADIATION-THERAPY AND CHEMOTHERAPY AT THE UNIVERSITY-OF-TEXAS M.D.-ANDERSON-CANCER-CENTER, 1967-1997, Radiology, 208(3), 1998, pp. 739-747
CHEMOTHERAPY INDUCES TRANSIENT SEX CHROMOSOMAL AND AUTOSOMAL ANEUPLOIDY IN HUMAN SPERM
Authors: ROBBINS WA MEISTRICH ML MOORE D HAGEMEISTER FB WEIER HU CASSEL MJ WILSON G ESKENAZI B WYROBEK AJ
Citation: Wa. Robbins et al., CHEMOTHERAPY INDUCES TRANSIENT SEX CHROMOSOMAL AND AUTOSOMAL ANEUPLOIDY IN HUMAN SPERM, Nature genetics, 16(1), 1997, pp. 74-78
PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA
Authors: YOUNES A RODRIGUEZ MA MCLAUGHLIN P NORTH L SARRIS AH PATE O HAGEMEISTER FB ROMAGUERA J PRETI A BACHIER C CABANILLAS F
Citation: A. Younes et al., PHASE-I STUDY OF FLUDARABINE AND PACLITAXEL FOR THE TREATMENT OF LOW-GRADE NON-HODGKINS-LYMPHOMA, Leukemia & lymphoma, 26(1-2), 1997, pp. 77-82
RAPID RECOVERY OF SPERMATOGENESIS AFTER MITOXANTRONE, VINCRISTINE, VINBLASTINE, AND PREDNISONE CHEMOTHERAPY FOR HODGKINS-DISEASE
Authors: MEISTRICH ML WILSON G MATHUR K FULLER LM RODRIGUEZ MA MCLAUGHLIN P ROMAGUERA JE CABANILLAS FF HA CS LIPSHULTZ LI HAGEMEISTER FB
Citation: Ml. Meistrich et al., RAPID RECOVERY OF SPERMATOGENESIS AFTER MITOXANTRONE, VINCRISTINE, VINBLASTINE, AND PREDNISONE CHEMOTHERAPY FOR HODGKINS-DISEASE, Journal of clinical oncology, 15(12), 1997, pp. 3488-3495
LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-1 HODGKINS-DISEASE- PATTERNS OF FAILURE, LATE TOXICITY AND 2ND MALIGNANCIES
Authors: VLACHAKI MT HA CS HAGEMEISTER FB FULLER LM RODRIGUEZ MA BESA PC HESS MA BROWN B CABANILLAS F COX JD
Citation: Mt. Vlachaki et al., LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-1 HODGKINS-DISEASE- PATTERNS OF FAILURE, LATE TOXICITY AND 2ND MALIGNANCIES, International journal of radiation oncology, biology, physics, 39(3), 1997, pp. 609-616
SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS
Authors: LIAO ZX HA CS FULLER LM HAGEMEISTER FB CABANILLAS F TUCKER SL HESS MA COX JD
Citation: Zx. Liao et al., SUBDIAPHRAGMATIC STAGE-I AND STAGE-II HODGKINS-DISEASE - LONG-TERM FOLLOW-UP AND PROGNOSTIC FACTORS, International journal of radiation oncology, biology, physics, 39(2), 1997, pp. 322-322
LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-I HODGKINS-DISEASE- PROGNOSTIC FACTORS FOR SURVIVAL AND FREEDOM FROM PROGRESSION
Authors: VLACHAKI MT HAGEMEISTER FB FULLER LM BESA PC HESS MA BROWN B CABANILLAS F COX JD
Citation: Mt. Vlachaki et al., LONG-TERM OUTCOME OF TREATMENT FOR ANN-ARBOR STAGE-I HODGKINS-DISEASE- PROGNOSTIC FACTORS FOR SURVIVAL AND FREEDOM FROM PROGRESSION, International journal of radiation oncology, biology, physics, 38(3), 1997, pp. 593-599
THE POST-THERAPY GALLIUM SCAN (GS) IN CLINICALLY STAGED SUPRADIAPHRAGMATIC I-II HODGKINS-DISEASE (HD) IS THE MOST IMPORTANT PREDICTOR OF FREEDOM FROM PROGRESSION (FFP)
Authors: HAGEMEISTER FB HA C ROMAGUERA J MCLAUGHLIN P RODRIGUEZ A YOUNES A SARRIS A CABANILLAS F TUCKER S HESS M COX J
Citation: Fb. Hagemeister et al., THE POST-THERAPY GALLIUM SCAN (GS) IN CLINICALLY STAGED SUPRADIAPHRAGMATIC I-II HODGKINS-DISEASE (HD) IS THE MOST IMPORTANT PREDICTOR OF FREEDOM FROM PROGRESSION (FFP), Blood, 90(10), 1997, pp. 3898-3898
HCVAD ARA-C-MTX (HCVAD/A-M) WITH OR WITHOUT HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSFUSION (SCT) AS SALVAGE FOR RELAPSED OR REFRACTORY DIFFUSE/MODULAR MANTLE CELL LYMPHOMA (MCL)/
Authors: ROMAGUERA J KHOURI I HAGEMEISTER FB RODRIGUEZ MA MCLAUGHLIN P SARRIS A YOUNES A KEATING MJ KOLLER C OBRIEN S RIGGS S KANTARJIAN H CHAMPLIN R CABANILLAS F
Citation: J. Romaguera et al., HCVAD ARA-C-MTX (HCVAD/A-M) WITH OR WITHOUT HIGH-DOSE CHEMOTHERAPY AND STEM-CELL TRANSFUSION (SCT) AS SALVAGE FOR RELAPSED OR REFRACTORY DIFFUSE/MODULAR MANTLE CELL LYMPHOMA (MCL)/, Blood, 90(10), 1997, pp. 834-834
PHASE-II STUDY OF TAXOL IN COMBINATION WITH MITOXANTRONE AND IFOSFAMIDE (MINT) WITH CONSOLIDATION ESHAP FOR LYMPHOMAS
Authors: ROMAGUERA J HAGEMEISTER FB MCLAUGHLIN P RODRIGUEZ MA BACHIER C PRETI H SARRIS AH WEBER D YOUNES A CABANILLAS F
Citation: J. Romaguera et al., PHASE-II STUDY OF TAXOL IN COMBINATION WITH MITOXANTRONE AND IFOSFAMIDE (MINT) WITH CONSOLIDATION ESHAP FOR LYMPHOMAS, Blood, 90(10), 1997, pp. 835-835
RANDOMIZED STUDY OF IDARBUBICIN (IDA) VS ADRIAMYCIN (ADRIA)-BASED COMBINATION CHEMOTHERAPY FOR AGGRESSIVE POOR-PROGNOSIS (TUMOR SCORE GREATER-THAN-OR-EQUAL-TO-3) NON-HODGKINS-LYMPHOMAS (APPNHL)
Authors: CABANILLAS F ROMAGUERA J HAGEMEISTER FB YOUNES A MCLAUGHLIN P SARRIS A RODRIGUEZ MA
Citation: F. Cabanillas et al., RANDOMIZED STUDY OF IDARBUBICIN (IDA) VS ADRIAMYCIN (ADRIA)-BASED COMBINATION CHEMOTHERAPY FOR AGGRESSIVE POOR-PROGNOSIS (TUMOR SCORE GREATER-THAN-OR-EQUAL-TO-3) NON-HODGKINS-LYMPHOMAS (APPNHL), Blood, 90(10), 1997, pp. 1093-1093
CLINICAL CORRELATES OF ELEVATED SERUM LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH UNTREATED HODGKINS-DISEASE
Authors: SEYMOUR JF TALPAZ M HAGEMEISTER FB CABANILLAS F KURZROCK R
Citation: Jf. Seymour et al., CLINICAL CORRELATES OF ELEVATED SERUM LEVELS OF INTERLEUKIN-6 IN PATIENTS WITH UNTREATED HODGKINS-DISEASE, The American journal of medicine, 102(1), 1997, pp. 21-28
HODGKINS-DISEASE - THE NEXT DECADE
Authors: HAGEMEISTER FB
Citation: Fb. Hagemeister, HODGKINS-DISEASE - THE NEXT DECADE, Leukemia & lymphoma, 21(1-2), 1996, pp. 53-61
HIGH-RATE OF PROLONGED REMISSIONS FOLLOWING COMBINED-MODALITY THERAPYFOR PATIENTS WITH LOCALIZED LOW-GRADE LYMPHOMA
Authors: SEYMOUR JF MCLAUGHLIN P FULLER LM HAGEMEISTER FB HESS M SWAN F ROMAGUERA J RODRIGUEZ MA BESA P COX J CABANILLAS F
Citation: Jf. Seymour et al., HIGH-RATE OF PROLONGED REMISSIONS FOLLOWING COMBINED-MODALITY THERAPYFOR PATIENTS WITH LOCALIZED LOW-GRADE LYMPHOMA, Annals of oncology, 7(2), 1996, pp. 157-163
PRELIMINARY EXPERIENCE WITH PACLITAXEL FOR THE TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE
Authors: YOUNES A CABANILLAS F MCLAUGHLIN PW HAGEMEISTER FB FARBER C SARRIS A PATE O MYERS J PORTLOCK C
Citation: A. Younes et al., PRELIMINARY EXPERIENCE WITH PACLITAXEL FOR THE TREATMENT OF RELAPSED AND REFRACTORY HODGKINS-DISEASE, Annals of oncology, 7(10), 1996, pp. 1083-1085
TREATMENT OF SMALL NON-CLEAVED CELL LYMPHOMA IN THE ADULT
Authors: HAGEMEISTER FB
Citation: Fb. Hagemeister, TREATMENT OF SMALL NON-CLEAVED CELL LYMPHOMA IN THE ADULT, Biomedicine & pharmacotherapy, 50(9), 1996, pp. 433-441
FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE - AN EFFECTIVE NEW REGIMEN FOR INDOLENT LYMPHOMA
Authors: MCLAUGHLIN P HAGEMEISTER FB ROMAGUERA JE SARRIS AH PATE O YOUNES A SWAN F KEATING M CABANILLAS F
Citation: P. Mclaughlin et al., FLUDARABINE, MITOXANTRONE, AND DEXAMETHASONE - AN EFFECTIVE NEW REGIMEN FOR INDOLENT LYMPHOMA, Journal of clinical oncology, 14(4), 1996, pp. 1262-1268
NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE
Authors: YOUNES A AYOUB JP HAGEMEISTER FB MCLAUGHLIN P SARRIS A RODRIGUEZ MA SWAN F ROMAGUERA JE MARTIN J CABANILLAS F
Citation: A. Younes et al., NO EFFECT OF 96-HOUR PACLITAXEL INFUSION IN PATIENTS WITH RELAPSED NON-HODGKINS-LYMPHOMA REFRACTORY TO A 3-HOUR INFUSION SCHEDULE, Journal of clinical oncology, 14(2), 1996, pp. 543-548
PROGNOSTIC IMPLICATIONS FOLLOWING AN INDETERMINATE NONDIAGNOSTIC WORK-UP OF LYMPHOMA
Authors: MOORE DF PRETI A TRAN SM HAGEMEISTER FB RODRIGUEZ MA MCLAUGHLIN P ROMAGUERA J SARRIS A YOUNES A MOORE DF CABANILLAS F
Citation: Df. Moore et al., PROGNOSTIC IMPLICATIONS FOLLOWING AN INDETERMINATE NONDIAGNOSTIC WORK-UP OF LYMPHOMA, Blood, 88(10), 1996, pp. 906-906
HCVAD MTX-ARAC - A NEW EFFECTIVE REGIMEN FOR DIFFUSE AND NODULAR MANTLE CELL LYMPHOMA (MCL)/
Authors: ROMAGUERA J KHOURI I KANTARJIAN H TEROLCASTERA MJ RODRIGUEZ MA HAGEMEISTER FB MCLAUGHLIN P YOUNES A SARRIS A BACHIER C PRETI HA PUGH W GARCIACONDE J CHAMPLIN R CABANILLAS F
Citation: J. Romaguera et al., HCVAD MTX-ARAC - A NEW EFFECTIVE REGIMEN FOR DIFFUSE AND NODULAR MANTLE CELL LYMPHOMA (MCL)/, Blood, 88(10), 1996, pp. 2261-2261
Risultati: 1-25 | 26-50 | 51-61